Cargando…

Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variation

Parkinson’s disease (PD) is a neurodegenerative disorder caused by a complex interplay of genetic and environmental factors. For the stratification of PD patients and the development of advanced clinical trials, including causative treatments, a better understanding of the underlying genetic archite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohnmacht, Jochen, May, Patrick, Sinkkonen, Lasse, Krüger, Rejko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2020
Materias:	Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242266/ https://www.ncbi.nlm.nih.gov/pubmed/32248367 http://dx.doi.org/10.1007/s00702-020-02184-0

Ejemplares similares

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
por: Krüger, Rejko, et al.
Publicado: (2017)

The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease
por: Grossmann, Dajana, et al.
Publicado: (2020)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
por: Farrer, Matthew J., et al.
Publicado: (2021)

Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
por: Mencke, Pauline, et al.
Publicado: (2020)

Multilingual Validation of the First French Version of Munich Dysphagia Test—Parkinson's Disease (MDT-PD) in the Luxembourg Parkinson's Study
por: Simons, Janine A., et al.
Publicado: (2019)

GBA-associated PD: chances and obstacles for targeted treatment strategies
por: Höglinger, Günter, et al.
Publicado: (2022)

Genetic testing for Parkinson’s disease in clinical practice
por: Gasser, Thomas
Publicado: (2023)

Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research
por: Rajan, Roopa, et al.
Publicado: (2020)

Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease
por: Falkenburger, Björn, et al.
Publicado: (2022)

Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022)

Unmet Needs of People With Parkinson's Disease and Their Caregivers During COVID-19-Related Confinement: An Explorative Secondary Data Analysis
por: Hanff, Anne-Marie, et al.
Publicado: (2021)

Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting
por: Bowring, Francesca, et al.
Publicado: (2022)

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
por: Tönges, Lars, et al.
Publicado: (2022)

The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023)

Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort
por: Binck, Sylvia, et al.
Publicado: (2020)

Corrigendum: Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort
por: Binck, Sylvia, et al.
Publicado: (2021)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Life style and Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2022)

Treatment of Parkinson’s disease in the advanced stage
por: Ossig, C., et al.
Publicado: (2013)

Small intestine dysfunction in Parkinson’s disease
por: Dutkiewicz, Justyna, et al.
Publicado: (2015)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
por: Smith, Laura J., et al.
Publicado: (2022)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Parkinson’s disease between internal medicine and neurology
por: Csoti, Ilona, et al.
Publicado: (2015)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Disease modification in Parkinsonism: obstacles and ways forward
por: Höllerhage, M., et al.
Publicado: (2022)

The use of wearables for the diagnosis and treatment of Parkinson’s disease
por: Reichmann, Heinz, et al.
Publicado: (2023)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Parkinson’s disease therapy: what lies ahead?
por: Wolff, Andreas, et al.
Publicado: (2023)

BrainNet Europe’s Code of Conduct for brain banking
por: Klioueva, Natasja M., et al.
Publicado: (2015)

Non-motor symptoms of Parkinson’s disease: the patient’s perspective
por: Breen, Kieran C., et al.
Publicado: (2012)

Flavor perception and the risk of malnutrition in patients with Parkinson’s disease
por: Roos, Dareia S., et al.
Publicado: (2018)

Parkinson’s: a syndrome rather than a disease?
por: Titova, Nataliya, et al.
Publicado: (2016)

Diagnostic accuracy of glabellar tap sign for Parkinson’s disease
por: Nuuttila, Simo, et al.
Publicado: (2021)

The pathobiological basis of depression in Parkinson disease: challenges and outlooks
por: Jellinger, Kurt A.
Publicado: (2022)

Gender differences in non-motor fluctuations in Parkinson’s disease
por: Donzuso, Giulia, et al.
Publicado: (2023)

Current and novel infusion therapies for patients with Parkinson's disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Reward and value coding by dopamine neurons in non-human primates
por: Alikaya, Aydin, et al.
Publicado: (2017)

Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
por: Cova, Ilaria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_en8t19fk3du6rcpdcblnd7eldu